Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1995 4
1996 1
1997 3
1998 11
1999 10
2000 9
2001 5
2002 12
2003 4
2004 4
2005 5
2006 4
2007 7
2008 14
2009 27
2010 24
2011 29
2012 23
2013 31
2014 24
2015 7
2016 10
2017 4
2018 7
2019 6
2020 6
2021 15
2022 11
2023 8
2024 10
2025 12
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

328 results

Results by year

Filters applied: . Clear all
Page 1
Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial.
Garon EB, Ciuleanu TE, Arrieta O, Prabhash K, Syrigos KN, Goksel T, Park K, Gorbunova V, Kowalyszyn RD, Pikiel J, Czyzewicz G, Orlov SV, Lewanski CR, Thomas M, Bidoli P, Dakhil S, Gans S, Kim JH, Grigorescu A, Karaseva N, Reck M, Cappuzzo F, Alexandris E, Sashegyi A, Yurasov S, Pérol M. Garon EB, et al. Among authors: syrigos kn. Lancet. 2014 Aug 23;384(9944):665-73. doi: 10.1016/S0140-6736(14)60845-X. Epub 2014 Jun 2. Lancet. 2014. PMID: 24933332 Clinical Trial.
Quantitative Protein Expression of Antibody-Drug Conjugate Targets in EGFR Mutated and Wild-type Non-Small Cell Lung Cancer.
Trontzas IP, He M, Wurtz A, Robbins CJ, Robinson N, Bates K, Liu M, Aung TN, Scott L, Chan N, Burela S, Schillo J, Liebler DC, Hill S, Morrison RD, Vathiotis I, Syrigos KN, Goldberg SB, Politi K, Rimm DL. Trontzas IP, et al. Among authors: syrigos kn. Clin Cancer Res. 2025 Jul 1;31(13):2767-2776. doi: 10.1158/1078-0432.CCR-24-3347. Clin Cancer Res. 2025. PMID: 40047548 Free PMC article.
Histologic Transformation in Cancer: The Path for Clinical Translation.
Vathiotis I, Banerjee A, Sen U, Saalfeld FC, Halder D, Charpidou A, Syrigos KN, Horinouchi H, Tewari AK, Dawson MA, Wermke M, Sen T. Vathiotis I, et al. Among authors: syrigos kn. Cancer Discov. 2025 Sep 4;15(9):1783-1793. doi: 10.1158/2159-8290.CD-24-1866. Cancer Discov. 2025. PMID: 40904097 Free PMC article. Review.
Robotic Bronchoscopy in Lung Cancer Diagnosis.
Skouras VS, Gkiozos I, Charpidou AG, Syrigos KN. Skouras VS, et al. Among authors: syrigos kn. Cancers (Basel). 2024 Mar 17;16(6):1179. doi: 10.3390/cancers16061179. Cancers (Basel). 2024. PMID: 38539514 Free PMC article. Review.
Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy.
Saalfeld FC, Möller J, Christopoulos P, Wenzel C, Rasokat A, Wang XA, Vathiotis I, König D, Illini O, Grohé C, Wiesweg M, Wesseler C, Schubart C, Pelusi N, Rohde G, Overbeck TR, Kirfel J, Alt J, Kauffmann-Guerrero D, Griesinger F, Kulhavy J, Allgäuer M, Klimova A, Schütz M, Aust DE, Hochmair MJ, Rothschild SI, Syrigos KN, Veluswamy R, Michels S, Stenzinger A, Jöhrens K, Wermke M. Saalfeld FC, et al. Among authors: syrigos kn. Eur J Cancer. 2024 Dec;213:115065. doi: 10.1016/j.ejca.2024.115065. Epub 2024 Oct 12. Eur J Cancer. 2024. PMID: 39423775 Free article.
Sarcoidosis-Like Reactions Induced by Checkpoint Inhibitors.
Gkiozos I, Kopitopoulou A, Kalkanis A, Vamvakaris IN, Judson MA, Syrigos KN. Gkiozos I, et al. Among authors: syrigos kn. J Thorac Oncol. 2018 Aug;13(8):1076-1082. doi: 10.1016/j.jtho.2018.04.031. Epub 2018 May 12. J Thorac Oncol. 2018. PMID: 29763666 Free article. Review.
Second-line therapy in pancreatic cancer.
Skoura E, Syrigos KN, Saif MW. Skoura E, et al. Among authors: syrigos kn. JOP. 2013 Mar 10;14(2):133-4. doi: 10.6092/1590-8577/1463. JOP. 2013. PMID: 23474554 Free article. Review.
328 results